Navigation Links
Inovio Pharmaceuticals' Malaria DNA Vaccine Demonstrates Robust Immune Responses in Animal Models
Date:8/15/2013

BLUE BELL, Pa., Aug. 15, 2013 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) announced today that its SynCon® DNA vaccine containing multiple malaria antigens delivered via its CELLECTRA® electroporation device demonstrated strong and durable antibody and T-cell immune responses in small animals and non-human primates. With these strong preclinical results, Inovio plans to initiate a phase I/IIa clinical trial next year.

These results appear in the American Society for Microbiology's peer-reviewed journal, Infection & Immunity, in a paper entitled: "Inducing humoral and cellular responses to multiple sporozoite and liver-stage malaria antigens using pDNA," authored by Inovio researchers and collaborators.

The World Health Organization estimated that in 2010 there were more than 200 million cases of malaria and almost 700,000 deaths due to malaria infection, the majority affecting young children in Africa. To date, the most advanced malaria vaccine candidate RTS,S, an adjuvanted recombinant protein vaccine, has not shown substantial protection in the key trial age group of infants. Scientists believe that a more effective malaria vaccine should generate both strong antibody and potent T-cell immune responses.

In this study, Inovio researchers and collaborators designed a highly optimized DNA vaccine composed of four sporozoite and liver-stage malaria antigens using Inovio's SynCon technology. These antigens were chosen because of their important role in the control or elimination of malaria infection. Delivered using Inovio's CELLECTRA delivery system, this malaria vaccine generated robust and long-lasting T-cell responses in both mice and non-human primates. Moreover, these vaccine-produced T-cells exhibited the functional ability to kill and eliminate malaria-infected cells. Researchers also found vaccine-induced CD8+, or "kille
'/>"/>

SOURCE Inovio Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Inovio Pharmaceuticals Reports 2013 Second Quarter Financial Results
2. Inovio Pharmaceuticals Responds to Market Activity
3. Inovio Pharmaceuticals Potent hTERT DNA Cancer Vaccine Shows Potential to Reduce Tumors and Prevent Tumor Recurrence
4. Synthetically Optimized HIF-1 Alpha DNA Delivered with Inovios Electroporation Technology Provides Significant Therapeutic Effects for Peripheral Arterial Disease in Animal Model
5. Todays Research: Inovio Pharma, Sequenom, Peregrine Pharma, Onyx Pharma, and Optimer Pharma
6. Inovio Pharmaceuticals to Present at OneMedForumNY 2013 Investor Conference
7. Inovios Universal H7N9 DNA Vaccine Generates First Protective Antibody Responses Against Virulent H7N9 Virus in 100% of Vaccinated Animals
8. Inovio Pharmaceuticals DNA Vaccine Against Ebola and Marburg Filoviruses Provides Complete Protection in Preclinical Challenge Study
9. Inovio Pharmaceuticals Universal H1N1 Influenza Vaccine Achieves Protective Immune Responses Comparable to Conventional Vaccine in Phase I Study
10. Inovio Pharmaceuticals Recognized With "Best Therapeutic Vaccine" and "Best Early Stage Biotech" Awards at World Vaccine Congress 2013
11. Inovio Pharmaceuticals & U.S. Army Receive $3.5 Million Biodefense Grant to Further Develop Mass Vaccination Device
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/29/2015)... , June 29, 2015 BiondVax ... preliminary results from its BVX-006 Phase II clinical trial ... In this trial, M-001 was injected intramuscularly to volunteers ... an administration of the 2014/15 season trivalent influenza vaccine ... safe and well tolerated and induced humoral immune responses, ...
(Date:6/29/2015)... 2015  Isis Pharmaceuticals, Inc. (NASDAQ: ISIS ) ... Russell 1000 Index, effective June 26, 2015. The Russell ... of the U.S. equity universe. It is a subset ... of the largest securities based on a combination of ... "We are pleased to be added to this important ...
(Date:6/29/2015)... SAN JOSE, Calif. , June 29, 2015 ... its expert medical workstation lineup. The high-powered, multi-functional ... th generation Intel® Haswell Core ... processor. Both provide significant data processing and computing ... visual performance, making the unit well suited for ...
Breaking Medicine Technology:BiondVax Presents BVX-006 Preliminary Phase II Results: the Universal Flu Vaccine at Higher Doses is Safe and Improves Immunogenicity in Older Adults 2BiondVax Presents BVX-006 Preliminary Phase II Results: the Universal Flu Vaccine at Higher Doses is Safe and Improves Immunogenicity in Older Adults 3ISIS Pharmaceuticals Promoted to the Large-Cap Russell 1000 Index 2ISIS Pharmaceuticals Promoted to the Large-Cap Russell 1000 Index 3Arbor Solution Introduces Multi-Function Medical Workstation with Large 21.5" True Flat Touch Screen 2Arbor Solution Introduces Multi-Function Medical Workstation with Large 21.5" True Flat Touch Screen 3
... , SAN FRANCISCO, Sept. 14 ... reported long-term data with vicriviroc, its investigational CCR5 receptor ... II VICTOR-E1 study in treatment-experienced HIV-infected patients. The ... durable virologic suppression and increased CD4 cell counts, and ...
... September 14 , - ... Ensure Patient Safety and Quality, Safeguard Hospital Reimbursement , ... and leading provider of advanced,solutions for healthcare that utilize ... integrated group of,hospitals and physician practices, will roll out ...
Cached Medicine Technology:Schering-Plough Reports Long-Term Vicriviroc Data From Phase II Open-Label Extension Study in Treatment-Experienced HIV-Infected Patients 2Schering-Plough Reports Long-Term Vicriviroc Data From Phase II Open-Label Extension Study in Treatment-Experienced HIV-Infected Patients 3Schering-Plough Reports Long-Term Vicriviroc Data From Phase II Open-Label Extension Study in Treatment-Experienced HIV-Infected Patients 4Schering-Plough Reports Long-Term Vicriviroc Data From Phase II Open-Label Extension Study in Treatment-Experienced HIV-Infected Patients 5Novant Health Rolls Out MEDai's Predictive Modeling Solution to Nine Hospitals in Three States 2Novant Health Rolls Out MEDai's Predictive Modeling Solution to Nine Hospitals in Three States 3Novant Health Rolls Out MEDai's Predictive Modeling Solution to Nine Hospitals in Three States 4
(Date:6/29/2015)... ... , ... Sublime Beauty NATURALS® introduces its new USDA Certified Organic Sesame Oil ... skincare and even culinary uses, was especially designed for Oil Pulling. , To ... Pulling can accomplish this. Oil Pulling is an Ayurvedic practice that is easy and ...
(Date:6/29/2015)... ... , ... Aespala Medspa and Plastic Surgery is proud to introduce the newest ... Dr. Dreyfuss received his medical degree from Emory University in Atlanta before completing a ... Fellowship at the University of Chicago. He has taught and practiced medicine in the ...
(Date:6/29/2015)... ... June 30, 2015 , ... Ticket Down is a reputable source for ... 4th of July weekend. Concertgoers can add promo/coupon code GRATEFUL-DEAD-2015 for added savings. ... to their innovative sound, will not want to miss what is sure to be ...
(Date:6/29/2015)... ... June 30, 2015 , ... ... of revised Guidelines for Neuro Musculoskeletal Thermography and Sympathetic Skin Response Studies.* , ... that were first published in 2006, are intended to aid physicians and thermal ...
(Date:6/29/2015)... ... ... An upcoming documentary for public television by the Sports Conflict Institute ... perspective on conflict in sports with guest speakers including sports culture and marketing guru ... the sports industry that will discuss challenges in competitive sports and how sports can ...
Breaking Medicine News(10 mins):Health News:New Product: Transform Wellness and Oral Health With This Ancient Ayurvedic Secret and Organic Product from Sublime Beauty NATURALS® 2Health News:Aespala Medspa and Plastic Surgery Welcomes New Plastic Surgeon to Oak Brook, IL Office 2Health News:Aespala Medspa and Plastic Surgery Welcomes New Plastic Surgeon to Oak Brook, IL Office 3Health News:Grateful Dead Tickets at Soldier Field in Chicago: Ticket Down Slashes Grateful Dead Tickets Prices in Chicago at Soldier Field 2Health News:Grateful Dead Tickets at Soldier Field in Chicago: Ticket Down Slashes Grateful Dead Tickets Prices in Chicago at Soldier Field 3Health News:American Academy of Thermology Publishes Revised 2015 Guidelines for Neuro-Musculoskeletal Thermography and Sympathetic Skin Response Studies 2Health News:American Academy of Thermology Publishes Revised 2015 Guidelines for Neuro-Musculoskeletal Thermography and Sympathetic Skin Response Studies 3Health News:Dr. Marc Williams Joins SCI and In America Sports Documentary 2Health News:Dr. Marc Williams Joins SCI and In America Sports Documentary 3
... of man. Often it is mistaken for manliness //and other ... to the size of the fingers in a man’s hand?,A ... just that. ,Finger length ratio is the ratio ... ring finger. The study says lower finger ratios are thought ...
... According to a recent study researchers say hunger may be ... researchers // studied 16 men who agreed to skip breakfast. ... evening. Participants were asked to consume sugary, salty or bitter ... not swallow the drinks, but instead spit them out after ...
... causes inflammation of the liver and can cause complications ... countries, the hepatitis B vaccine is recommended for infants. ... protects against infection for up to 10 years. However, ... past 10 years. ,Researchers followed eight-hundred-and-forty-one Alaska natives ...
... is a sleep disorder where a person's breathing stops or ... collapsed airway. This can result in a number of serious ... nine-times more likely to have diabetes than those without the ... researchers say patients with type 2 diabetes who also suffer ...
... that Autism had been on the rise in Japan, even after ... children. ,MMR vaccine is one of the must-have vaccines ... by WHO. ,An edition of the journal Lancet in 1998 ... autism in children. Based on the report, there had been considerable ...
... show that certain form of herpes virus called Kaposi sarcoma– ... be treated with by glycyrrhizic acid (GA) for total recovery. ... can cause cancer by lying suppressed in the infected cells ... to treat all sorts of viral infections, which prevents or ...
Cached Medicine News:
... sophisticated Aumated Immunoassay Analyzer that fits in any ... 16 X 16 X 21 inches and weighs ... for physician office laboratories, work stations for small ... well as a dedicated system for specialty testing. ...
... ECi brings true automation and continuous ... Highly sensitive assays for thyroid, anemia, ... metabolism testing are currently available, with ... Vitros ECi can simultaneously process 60 ...
... the Therapeutic Drug Monitoring Market in 1981 ... in use today, this system uses technology ... measure serum drug concentration in a patient. ... different diseases, often exhibit a narrow therapeutic ...
Architect i2000 is a flexible solution for your evolving laboratory providing high throughput and walkaway time with built-in flexibility....
Medicine Products: